NEW YORK, Dec. 14, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INSG, AMPE, MARA, RGLS, and BCRX.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • INSG: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=INSG&prnumber=121420202
  • AMPE: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=AMPE&prnumber=121420202
  • MARA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=MARA&prnumber=121420202
  • RGLS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=RGLS&prnumber=121420202
  • BCRX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=BCRX&prnumber=121420202

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-inseego-corp-ampio-pharmaceuticals-marathon-patent-group-regulus-therapeutics-or-biocryst-pharmaceuticals-301192087.html

SOURCE InvestorsObserver